TL;DR: A 2025-era systematic review and meta-analysis of 14 studies links the LRP5 rs3736228 (Ala1330Val) variant to higher osteoporosis and fracture risk, with the strongest signals in males and in population-based control groups. Because the study is a candidate-gene meta-analysis with limited subgroup sample sizes, these findings are suggestive rather than settled.
The LRP5 gene encodes a co-receptor in the Wnt signaling pathway, which regulates bone formation and skeletal metabolism. The rs3736228 polymorphism, which swaps alanine for valine at position 1330, has already been established as a genome-wide significant locus for bone mineral density and fracture risk in large genome-wide association studies (GWAS). Those GWAS findings are the backdrop for this work, which asked a narrower question: do the effects differ across sex, menopausal status, ethnicity, and other clinical subgroups that large GWAS cohorts often underrepresent?
The authors pooled 14 studies (16 independent comparisons) including 1,549 patients and 3,345 controls, searching five databases and following PRISMA guidelines. Heterogeneity was assessed with Cochran's Q and I² statistics, with fixed-effects or random-effects models chosen accordingly. Across the overall analysis, the variant was associated with higher osteoporosis and fracture risk under the allelic model (OR = 1.17, 95% CI 1.04 to 1.31), homozygous model (OR = 1.47, 95% CI 1.07 to 2.01), dominant model (OR = 1.44, 95% CI 1.05 to 2.97), and recessive model (OR = 1.16, 95% CI 1.01 to 1.33). The heterozygous model did not reach significance (OR = 1.34, 95% CI 0.96 to 1.88, P = 0.09).
The subgroup results are where the study adds the most, and also where caution matters most. In males, the allelic and dominant models were significant (allelic OR = 1.59; dominant OR = 1.74). In females, the homozygous and recessive models reached significance (OR = 1.50 and 1.48, respectively). Population-based control groups showed significant associations across all four genetic models, while hospital-based controls did not. Meta-regression indicated that disease type, publication year, and control source together explained part of the between-study heterogeneity.
The authors themselves note that the associations appeared less robust in males and premenopausal females, and that subgroup sample sizes were limited. The pattern of effects differing by model and by subgroup also raises the possibility of selection and publication effects, which candidate-gene meta-analyses are prone to. The overall direction of the finding is consistent with GWAS evidence, but the subgroup-specific estimates should be treated as hypotheses for future testing rather than established risk stratification tools.
The most important takeaway is that a single common genetic variant contributes a modest, population-level increase in fracture and osteoporosis risk, and that this contribution is measurable but not deterministic. Carrying the variant does not mean fracture is inevitable, and the study does not provide a validated way to use rs3736228 in individual clinical decisions.
Bone health is shaped by many factors that are modifiable regardless of genotype. Resistance training is among the most consistently supported habits for maintaining bone mineral density, and it is worth discussing with a clinician if bone health is a concern. Adequate vitamin D and vitamin K2 status are commonly discussed in the context of bone metabolism, though the evidence for supplementation in people without deficiency is mixed and should be reviewed with a healthcare provider. Dietary protein intake, adequate calcium, and avoiding smoking and heavy alcohol use also have supporting evidence for skeletal health.
If you are interested in your own genetic risk profile, the appropriate path is a conversation with a physician or genetic counselor who can interpret results in the context of your overall health, family history, and bone density testing.
| Field | Detail |
|---|---|
| Title | Association of rs3736228 polymorphism in LRP5 gene with bone fracture and osteoporosis: a systematic review and updated meta-analysis |
| Study type | Systematic review and meta-analysis (PRISMA) |
| Sample size | 1,549 patients; 3,345 controls (14 studies, 16 comparisons) |
| Journal | BMC Musculoskeletal Disorders |
| PubMed ID | 42907799 |
| Key outcomes | Osteoporosis and fracture risk across allelic, homozygous, dominant, recessive, and heterozygous models |
| Limitations noted | Limited subgroup sample sizes; heterogeneity; candidate-gene design |
1. Association of rs3736228 polymorphism in LRP5 gene with bone fracture and osteoporosis: a systematic review and updated meta-analysis. *BMC Musculoskeletal Disorders*. PubMed. https://pubmed.ncbi.nlm.nih.gov/42907799/
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.